Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma
Journal of the National Comprehensive Cancer Network · 2025
DOI: 10.6004/jnccn.2025.7056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025. Verfasst von Andrea Baudo und 18 weiteren Autor:innen. Beteiligte Einrichtung: 1Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Retroperitoneal Neoplasms, Leiomyosarcoma, Liposarcoma, Sarcoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Among patients with nonmetastatic retroperitoneal sarcoma, the use of radiotherapy (RT) use and its association with survival following surgical treatment remain unknown. Patients and Methods: Patients with surgically treated, nonmetastatic retroperitoneal well-differentiated, dedifferentiated liposarcoma, and leiomyosarcoma were identified within the SEER database (2004–2020). We used estimated annual percentage change (EAPC) analyses, multivariable logistic regression (LR) models, Kaplan-Meier survival plots, and multivariable Cox regression (MCR) models to evaluate treatment patterns and outcomes.
Results
Perioperative radiotherapy (RT) was delivered to 96 (16%) of 582 patients with well-differentiated liposarcoma, 211 (29%) of 739 patients with dedifferentiated liposarcoma, and 247 (35%) of 703 patients with leiomyosarcoma. Over time, the rate of perioperative RT use decreased from 27.3% to 5.4% for well-differentiated liposarcoma (EAPC, –3.5%; P =.02), but remained stable for dedifferentiated liposarcoma ( P =.9) and leiomyosarcoma ( P =.055). In multivariable LR, dedifferentiated liposarcoma (odds ratio [OR], 1.99; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
- 2Department of Urology, IRCCS Policlinico San Donato, Milan, Italy.
- 3Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- 4Vita-Salute San Raffaele University, Milan, Italy.
- 5Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
- 6Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Zitieren
APA
Baudo, A., de Angelis, M., Siech, C., Jannello, L. M. I., Di Bello, F., Goyal, J. A., Tian, Z., Acquati, P., Conti, A., Vizziello, D., Briganti, A., Chun, F. K. H., de Cobelli, O., Longo, N., Califano, G., Saad, F., Shariat, S. F., Carmignani, L., & Karakiewicz, P. I. (2025). Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2025.7056
Vancouver
Baudo A, de Angelis M, Siech C, Jannello LMI, Di Bello F, Goyal JA, et al. Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma. Journal of the National Comprehensive Cancer Network. 2025. doi:10.6004/jnccn.2025.7056
BibTeX
@article{Baudo2025,
author = {Baudo, Andrea and de Angelis, Mario and Siech, Carolin and Jannello, Letizia Maria Ippolita and Di Bello, Francesco and Goyal, Jordan A and Tian, Zhe and Acquati, Pietro and Conti, Andrea and Vizziello, Damiano and Briganti, Alberto and Chun, Felix K H and de Cobelli, Ottavio and Longo, Nicola and Califano, Gianluigi and Saad, Fred and Shariat, Shahrokh F and Carmignani, Luca and Karakiewicz, Pierre I},
title = {Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
doi = {10.6004/jnccn.2025.7056}
}
EUVIMED